| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 24 | 2024 | 1234 | 6.190 |
Why?
|
| Heart Defects, Congenital | 27 | 2024 | 1682 | 5.640 |
Why?
|
| Cardiac Output, Low | 5 | 2020 | 81 | 2.790 |
Why?
|
| Norwood Procedures | 4 | 2022 | 81 | 2.560 |
Why?
|
| Hemodynamics | 13 | 2022 | 941 | 2.190 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 3 | 2023 | 76 | 1.580 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2022 | 215 | 1.560 |
Why?
|
| Sodium Bicarbonate | 2 | 2022 | 59 | 1.540 |
Why?
|
| Cardiotonic Agents | 3 | 2019 | 155 | 1.390 |
Why?
|
| Capnography | 2 | 2020 | 15 | 1.360 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2022 | 133 | 1.320 |
Why?
|
| Child | 49 | 2024 | 29125 | 1.290 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 125 | 1.220 |
Why?
|
| Cardiopulmonary Bypass | 6 | 2021 | 423 | 1.100 |
Why?
|
| Hospitalization | 11 | 2023 | 2117 | 1.080 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 453 | 1.070 |
Why?
|
| Length of Stay | 10 | 2023 | 1929 | 1.060 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 747 | 1.040 |
Why?
|
| Infant | 27 | 2023 | 13297 | 1.030 |
Why?
|
| Critical Care | 6 | 2023 | 771 | 1.020 |
Why?
|
| Betacoronavirus | 2 | 2020 | 527 | 1.010 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1153 | 0.980 |
Why?
|
| Point-of-Care Systems | 2 | 2023 | 195 | 0.980 |
Why?
|
| Oximetry | 6 | 2022 | 172 | 0.970 |
Why?
|
| Coronavirus Infections | 3 | 2021 | 651 | 0.950 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 715 | 0.940 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 36 | 0.940 |
Why?
|
| Postoperative Care | 6 | 2020 | 738 | 0.930 |
Why?
|
| Tetralogy of Fallot | 2 | 2023 | 149 | 0.900 |
Why?
|
| Vasoconstrictor Agents | 3 | 2020 | 151 | 0.870 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 585 | 0.790 |
Why?
|
| Inpatients | 3 | 2023 | 688 | 0.790 |
Why?
|
| Postoperative Period | 6 | 2022 | 667 | 0.790 |
Why?
|
| Pulmonary Surfactants | 1 | 2021 | 50 | 0.780 |
Why?
|
| Pacemaker, Artificial | 1 | 2024 | 214 | 0.780 |
Why?
|
| Chylothorax | 1 | 2021 | 35 | 0.760 |
Why?
|
| Diuretics | 2 | 2019 | 171 | 0.750 |
Why?
|
| Humans | 83 | 2024 | 262184 | 0.750 |
Why?
|
| Cardiac Output | 2 | 2022 | 193 | 0.740 |
Why?
|
| Dexmedetomidine | 1 | 2021 | 85 | 0.740 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 99 | 0.740 |
Why?
|
| Postoperative Complications | 7 | 2024 | 5565 | 0.720 |
Why?
|
| Milrinone | 1 | 2019 | 33 | 0.710 |
Why?
|
| Pandemics | 5 | 2021 | 1567 | 0.710 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2021 | 194 | 0.710 |
Why?
|
| Drug Utilization | 2 | 2019 | 180 | 0.710 |
Why?
|
| Heart Arrest | 2 | 2021 | 360 | 0.710 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 1303 | 0.700 |
Why?
|
| Neutrophils | 3 | 2023 | 834 | 0.700 |
Why?
|
| Blood Pressure | 7 | 2022 | 1465 | 0.690 |
Why?
|
| Triiodothyronine | 1 | 2019 | 77 | 0.690 |
Why?
|
| Acidosis | 1 | 2020 | 117 | 0.680 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 330 | 0.680 |
Why?
|
| Critical Illness | 3 | 2020 | 714 | 0.680 |
Why?
|
| Lymphocytes | 3 | 2023 | 1229 | 0.670 |
Why?
|
| Infant, Premature, Diseases | 1 | 2021 | 246 | 0.670 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 601 | 0.650 |
Why?
|
| Pulmonary Atresia | 3 | 2023 | 41 | 0.640 |
Why?
|
| Lung | 2 | 2020 | 3162 | 0.620 |
Why?
|
| Clinical Deterioration | 1 | 2017 | 13 | 0.620 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 548 | 0.610 |
Why?
|
| Retrospective Studies | 29 | 2023 | 38006 | 0.600 |
Why?
|
| Infant, Newborn | 14 | 2023 | 8224 | 0.600 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 220 | 0.600 |
Why?
|
| Hypothyroidism | 1 | 2019 | 205 | 0.600 |
Why?
|
| Multiple Organ Failure | 2 | 2023 | 178 | 0.600 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 191 | 0.590 |
Why?
|
| Hospital Rapid Response Team | 1 | 2017 | 37 | 0.590 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 205 | 0.590 |
Why?
|
| Nitric Oxide | 2 | 2020 | 644 | 0.560 |
Why?
|
| Oxygen | 7 | 2022 | 754 | 0.550 |
Why?
|
| Cause of Death | 1 | 2019 | 755 | 0.540 |
Why?
|
| Vascular Resistance | 2 | 2020 | 197 | 0.540 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2020 | 299 | 0.540 |
Why?
|
| Child, Preschool | 13 | 2021 | 16249 | 0.540 |
Why?
|
| Heart Failure | 2 | 2021 | 2523 | 0.530 |
Why?
|
| Intensive Care Units, Pediatric | 5 | 2023 | 441 | 0.530 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2015 | 21 | 0.530 |
Why?
|
| Scimitar Syndrome | 1 | 2016 | 53 | 0.510 |
Why?
|
| Anesthesia | 1 | 2018 | 296 | 0.500 |
Why?
|
| Aortic Coarctation | 1 | 2016 | 101 | 0.500 |
Why?
|
| Ketamine | 1 | 2018 | 234 | 0.500 |
Why?
|
| Hypotension | 3 | 2022 | 211 | 0.490 |
Why?
|
| Treatment Outcome | 18 | 2023 | 32986 | 0.480 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 175 | 0.470 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 222 | 0.470 |
Why?
|
| Vena Cava, Superior | 2 | 2021 | 78 | 0.470 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 255 | 0.450 |
Why?
|
| Heart | 3 | 2023 | 1225 | 0.440 |
Why?
|
| Echocardiography | 4 | 2021 | 1177 | 0.430 |
Why?
|
| Ventricular Septum | 2 | 2022 | 20 | 0.430 |
Why?
|
| Lactates | 2 | 2022 | 113 | 0.430 |
Why?
|
| Aneurysm | 1 | 2012 | 94 | 0.410 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2022 | 181 | 0.410 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 320 | 0.410 |
Why?
|
| Intensive Care Units | 5 | 2022 | 717 | 0.390 |
Why?
|
| Leukocyte Count | 3 | 2021 | 683 | 0.380 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 547 | 0.380 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 4330 | 0.360 |
Why?
|
| Hypertension | 2 | 2020 | 1514 | 0.360 |
Why?
|
| Disease Management | 1 | 2015 | 1060 | 0.350 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 526 | 0.350 |
Why?
|
| Fontan Procedure | 2 | 2022 | 154 | 0.330 |
Why?
|
| Risk Factors | 9 | 2023 | 17606 | 0.330 |
Why?
|
| Preoperative Period | 2 | 2020 | 344 | 0.320 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 828 | 0.300 |
Why?
|
| Vasopressins | 3 | 2021 | 62 | 0.290 |
Why?
|
| Heart Ventricles | 3 | 2022 | 847 | 0.290 |
Why?
|
| Cardiology | 2 | 2022 | 530 | 0.270 |
Why?
|
| Sepsis | 2 | 2022 | 655 | 0.270 |
Why?
|
| Adolescent | 8 | 2024 | 31247 | 0.260 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 193 | 0.260 |
Why?
|
| Hospital Mortality | 3 | 2021 | 1308 | 0.260 |
Why?
|
| Carbon Dioxide | 3 | 2022 | 317 | 0.260 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 497 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 2632 | 0.250 |
Why?
|
| Stroke | 2 | 2023 | 1155 | 0.240 |
Why?
|
| Tidal Volume | 2 | 2020 | 57 | 0.230 |
Why?
|
| Age Factors | 4 | 2021 | 5385 | 0.220 |
Why?
|
| Male | 17 | 2023 | 123269 | 0.220 |
Why?
|
| Competency-Based Education | 1 | 2023 | 79 | 0.220 |
Why?
|
| Female | 18 | 2023 | 142232 | 0.210 |
Why?
|
| Prospective Studies | 5 | 2021 | 12914 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2020 | 2234 | 0.210 |
Why?
|
| Gases | 1 | 2022 | 36 | 0.210 |
Why?
|
| Ultrasonography | 3 | 2023 | 1866 | 0.210 |
Why?
|
| Steroids | 1 | 2024 | 356 | 0.210 |
Why?
|
| Bicarbonates | 1 | 2022 | 131 | 0.210 |
Why?
|
| Airway Extubation | 1 | 2022 | 65 | 0.210 |
Why?
|
| Respiration, Artificial | 3 | 2021 | 579 | 0.210 |
Why?
|
| Administration, Inhalation | 2 | 2020 | 286 | 0.210 |
Why?
|
| Cardiovascular System | 1 | 2023 | 142 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 14902 | 0.200 |
Why?
|
| Surface-Active Agents | 1 | 2021 | 41 | 0.200 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2021 | 32 | 0.200 |
Why?
|
| Thoracic Duct | 1 | 2021 | 16 | 0.200 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 117 | 0.200 |
Why?
|
| Dialysis | 1 | 2021 | 23 | 0.200 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 250 | 0.190 |
Why?
|
| Fluid Therapy | 1 | 2022 | 181 | 0.190 |
Why?
|
| Bland White Garland Syndrome | 1 | 2020 | 1 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2021 | 71 | 0.190 |
Why?
|
| Ligation | 1 | 2021 | 193 | 0.190 |
Why?
|
| Nicardipine | 1 | 2020 | 14 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2021 | 172 | 0.180 |
Why?
|
| Japan | 1 | 2020 | 227 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2023 | 191 | 0.180 |
Why?
|
| Nitroprusside | 1 | 2020 | 49 | 0.180 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 1381 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 203 | 0.180 |
Why?
|
| Biomarkers | 2 | 2022 | 5052 | 0.180 |
Why?
|
| Antithrombins | 1 | 2020 | 74 | 0.180 |
Why?
|
| Malnutrition | 1 | 2023 | 219 | 0.180 |
Why?
|
| Interactive Ventilatory Support | 1 | 2019 | 1 | 0.180 |
Why?
|
| Blood Gas Analysis | 1 | 2019 | 100 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 220 | 0.180 |
Why?
|
| Time Factors | 5 | 2020 | 12969 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 211 | 0.170 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 51 | 0.170 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 26 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 587 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 193 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 324 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 257 | 0.170 |
Why?
|
| Anesthetics, Dissociative | 1 | 2018 | 22 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 399 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6105 | 0.160 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 63 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 366 | 0.160 |
Why?
|
| Thyroxine | 1 | 2018 | 116 | 0.160 |
Why?
|
| Bayes Theorem | 1 | 2022 | 1032 | 0.160 |
Why?
|
| Patient Admission | 1 | 2019 | 222 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 472 | 0.150 |
Why?
|
| Methylprednisolone | 1 | 2018 | 193 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2021 | 6892 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 4755 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 104 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 385 | 0.150 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 31 | 0.140 |
Why?
|
| Hydrocortisone | 1 | 2018 | 389 | 0.140 |
Why?
|
| Arginine Vasopressin | 1 | 2016 | 60 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 338 | 0.140 |
Why?
|
| Pneumonia | 1 | 2022 | 754 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2017 | 301 | 0.140 |
Why?
|
| Ventricular Function | 1 | 2016 | 94 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2017 | 429 | 0.130 |
Why?
|
| Triage | 1 | 2017 | 251 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 718 | 0.130 |
Why?
|
| Resuscitation | 1 | 2017 | 222 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 125 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 1015 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 216 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 1405 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 637 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 1292 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2018 | 563 | 0.120 |
Why?
|
| United States | 3 | 2021 | 15561 | 0.120 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 226 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2015 | 602 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 1173 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 2153 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2597 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3023 | 0.100 |
Why?
|
| Registries | 1 | 2019 | 2187 | 0.100 |
Why?
|
| Palliative Care | 1 | 2022 | 2032 | 0.100 |
Why?
|
| Prognosis | 2 | 2020 | 21745 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 2515 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 544 | 0.090 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 686 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 928 | 0.090 |
Why?
|
| Incidence | 1 | 2021 | 5709 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 5008 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 563 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6219 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2019 | 9186 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8883 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 78082 | 0.060 |
Why?
|
| Glasgow Coma Scale | 1 | 2023 | 215 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 28 | 0.050 |
Why?
|
| Sample Size | 1 | 2022 | 203 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 26 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 181 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 23 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 269 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 322 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 244 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 68 | 0.050 |
Why?
|
| Seasons | 1 | 2022 | 340 | 0.050 |
Why?
|
| Calcitonin | 1 | 2021 | 186 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 163 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 249 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 339 | 0.050 |
Why?
|
| Bibliometrics | 1 | 2021 | 71 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2021 | 240 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7577 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2021 | 477 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 7551 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 107 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 487 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2022 | 349 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 306 | 0.040 |
Why?
|
| Publishing | 1 | 2021 | 222 | 0.040 |
Why?
|
| Chest Tubes | 1 | 2019 | 102 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 180 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 319 | 0.040 |
Why?
|
| Heparin | 1 | 2020 | 360 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 497 | 0.040 |
Why?
|
| Diaphragm | 1 | 2019 | 181 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 574 | 0.040 |
Why?
|
| Heart Rate | 1 | 2020 | 736 | 0.040 |
Why?
|
| Respiration | 1 | 2019 | 447 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2019 | 222 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 943 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 601 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 2394 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 788 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 6038 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 70323 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 86445 | 0.010 |
Why?
|